Literature DB >> 9851803

COUP-TFI expression in human adrenocortical adenomas: possible role in steroidogenesis.

H Shibata1, T Ando, T Suzuki, I Kurihara, K Hayashi, M Hayashi, I Saito, M Murai, T Saruta.   

Abstract

Chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is an orphan nuclear receptor essential for neurogenesis, organogenesis, and cell fate determination. CYP17 gene transcription has recently been shown to be activated by SF-1 (steroidogenic factor-1) binding to a cyclic AMP-responsive sequence within the promoter region of the gene, and inhibited by COUP-TF binding to the sequence. Thus, COUP-TF and SF-1 act as a transcriptional repressor and activator, respectively, of CYP17 gene expression. Transcriptional repression by COUP-TFI is mediated by corepressors, N-CoR (nuclear receptor-corepressor) and SMRT (silencing mediator for retinoid and thyroid hormone-receptor), whereas transcriptional activation by SF-1 is mediated by coactivator SRC-1 (steroid receptor coactivator-1). We therefore examined the expression of COUP-TFI, SF-1, SRC-1, N-CoR, and SMRT in a variety of adrenocortical adenomas and compared the results with CYP17 mRNA levels. We found significantly high COUP-TFI mRNA expression in nonfunctional adenomas (n=8: 220+/-16%; normal 96+/-4%), a deoxycorticosterone-producing adenoma (n=1: 200%), and a pre-clinical Cushing's adenoma (n=1: 280%), intermediate COUP-TFI expression in cortisol-producing adenomas (n=8: 63+/-5%), and low COUP-TFI expression in aldosterone-producing adenomas (n=8: 49+/-4%). In contrast to COUP-TFI, SF-1 mRNA expression did not vary significantly among adrenals. We did not detect the expected negative correlation between COUP-TFI and CYP17 mRNA levels in adrenocortical adenomas. High COUP-TFI expression was associatedwith a nonfunctioning phenotype. Interestingly, the pattern of COUP-TFI expression was similar to the profile of N-CoR expression, but not of SMRT expression. These results indicate that COUP-TFI and N-CoR may play a role in steroidogenesis by human adrenocortical adenomas.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9851803     DOI: 10.1210/jcem.83.12.5470

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Lysine deacetylase inhibition attenuates hypertension and is accompanied by acetylation of mineralocorticoid receptor instead of histone acetylation in spontaneously hypertensive rats.

Authors:  Young Mi Seok; Hae Ahm Lee; Kwon Moo Park; Mi-Hyang Hwangbo; In Kyeom Kim
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-04-22       Impact factor: 3.000

2.  Coactivation of SF-1-mediated transcription of steroidogenic enzymes by Ubc9 and PIAS1.

Authors:  Noriko Suda; Hirotaka Shibata; Isao Kurihara; Yayoi Ikeda; Sakiko Kobayashi; Kenichi Yokota; Ayano Murai-Takeda; Ken Nakagawa; Mototsugu Oya; Masaru Murai; William E Rainey; Takao Saruta; Hiroshi Itoh
Journal:  Endocrinology       Date:  2011-04-05       Impact factor: 4.736

3.  Transcriptional regulation of the fucosyltransferase VI gene in hepatocellular carcinoma cells.

Authors:  Koji Higai; Noriko Miyazaki; Yutaro Azuma; Kojiro Matsumoto
Journal:  Glycoconj J       Date:  2008-02-15       Impact factor: 2.916

4.  Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas.

Authors:  Brandi Howard; Yonghong Wang; Paraskevi Xekouki; Fabio R Faucz; Meenu Jain; Lisa Zhang; Paul G Meltzer; Constantine A Stratakis; Electron Kebebew
Journal:  J Clin Endocrinol Metab       Date:  2013-12-11       Impact factor: 5.958

5.  The roles of testicular orphan nuclear receptor 4 (TR4) in cerebellar development.

Authors:  Yei-Tsung Chen; Loretta L Collins; Shu-Shi Chang; Chawnshang Chang
Journal:  Cerebellum       Date:  2008       Impact factor: 3.847

6.  Expression of aromatase and estrogen receptors in human adrenocortical tumors.

Authors:  Luisa Barzon; Giulia Masi; Monia Pacenti; Marta Trevisan; Francesco Fallo; Andrea Remo; Guido Martignoni; Daniela Montanaro; Vincenzo Pezzi; Giorgio Palù
Journal:  Virchows Arch       Date:  2007-12-21       Impact factor: 4.535

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.